Vnitr Lek 2010, 56(Suppl 2):91-93

Langerhans cell histiocytosis - cutaneous aspects of the disease

V. Vašků
I. dermatovenerologická klinika Lékařské fakulty MU a FN u sv. Anny Brno, přednosta doc. MUDr. Vladimír Vašků, CSc.

There is discussed nature of Langerhans cell histiocytosis - reactive versus neoplastic. It represents wide clinical spectrum with localised or disseminated types of the disease. Skin lesions are very common and they could be the first symptoms. Usually involved is the scalp and trunk area. The involvement of nails and mucous membranes is possible. From treatment modalities, PUVA (photochemotherapy) is very important and it's best mode is systemic admission of psoralen with subsequent irradiation by defined part of UVA range. It can be considered as the first choice treatment for skin lesions.

Keywords: Langerhans cell histiocytosis; cutaneous lesions; treatment

Received: September 9, 2010; Published: April 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vašků V. Langerhans cell histiocytosis - cutaneous aspects of the disease. Vnitr Lek. 2010;56(Supplementum 2):91-93.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Braun-Falco O, Plewig G, Wolff HH. Dermatológia a venerológia. Prvé slovenské a české vydanie. Martin: Osveta 2001: 1321-1327. Go to original source...
    2. Bolognia JL, Jorizzo JL, Rapini RP. Dermatology. 2nd ed. Philadelphia: Mosby Elsevier 2008: 1395-1400.
    3. Wolff K, Goldsmith LA, Katz SI et al. Fitzpatrick's dermatology in general medicine. 7th ed. New York: McGraw Hill 2008: 1414-1420.

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.